Sleep Apnea Reduced in People Who Took Zepbound, Eli Lilly Reports

The company reported results of clinical trials involving Zepbound, an obesity drug in the same class as Novo Nordisk ’s Wegovy.
Source: NYT Health - Category: Consumer Health News Authors: Tags: Tirzepatide Apnea (Sleep Disorder) Drugs (Pharmaceuticals) Obesity Weight Clinical Trials Eli Lilly and Company Source Type: news